The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence

被引:0
|
作者
Salimovic-Besic, Irma [1 ]
Dedeic-Ljubovic, Amela [1 ]
Zahirovic, Edina [1 ]
Hasanovic, Medina [1 ]
Sehic, Merima [1 ]
Vukovikj, Maja [2 ]
Boshevska, Golubinka [3 ]
Vegar-Zubovic, Sandra [1 ]
Mehmedika-Suljic, Enra [1 ]
Izetbegovic, Sebija [1 ]
机构
[1] Univ Sarajevo, Clin Ctr, Bolnicka 25, Sarajevo 71000, Bosnia & Herceg
[2] Inst Publ Hlth Republ North Macedonia, 50-Ta Div 6, Skopje 1000, North Macedonia
[3] Univ Goce Delchev, Fac Med Sci, Krste Misirkov 10-A POB 201, Shtip 2000, North Macedonia
关键词
SARS-CoV-2; N501Y; Delta variant; Omicron variant; COVID-19; Pandemic; Spike protein; RECEPTOR-BINDING DOMAIN; ACCURATE; ACE2;
D O I
10.1016/j.heliyon.2022.e12650
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Circulation of the Omicron variant with the reemergence of the N501Y mutation along with many others in the spike protein has once again stirred the academic community. Interestingly, tracing the genetic diversity of SARS-CoV-2 shed light on a less frequent N501Y + Delta variant which has been in the global circulation for some time before the Omicron appearance. This paper aims to present the molecular characteristics of the SARS-CoV-2 Spike_N501Y + Delta variant detected in Bosnia and Herzegovina. The study was conducted during November and December 2021. All patients were tested using real-time RT-PCR for detection of SARS-CoV-2. A representative number of SARS-CoV-2 positive samples was pre-screened using VirSNiP SARS-CoV-2 Spike N501Y kit. The characterization of the viruses was carried out with Illumina RNA Prep with enrichment and the Respiratory Virus Oligo Panel kit. Among the analyzed sequences, we found two isolates of the Delta variant that differ from their most related clade- GK AY.4.3 in additional mutations N501Y and L54F. In this study, we described the presence of a rare form of Delta variant with Spike_N501Y mutation in the shadow of the Omicron emergence. Despite the set of mutations in the Spike protein, this form of Delta variant does not indicate the large-scale consequences for the general population. Further functional studies of this form could provide more information about its antigenicity and infectivity.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
    Sakai-Tagawa, Yuko
    Yamayoshi, Seiya
    Halfmann, Peter J.
    Kawaoka, Yoshihiro
    VIRUSES-BASEL, 2021, 13 (11):
  • [22] SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise
    Shook, Lydia L.
    Brigida, Sara
    Regan, James
    Flynn, James P.
    Mohammadi, Abbas
    Etemad, Behzad
    Siegel, Molly R.
    Clapp, Mark A.
    Li, Jonathan Z.
    Roberts, Drucilla J.
    Edlow, Andrea G.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (05): : 754 - 758
  • [23] SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
    Lowry, Kym
    Wang, Claire
    Bordin, Amanda
    Buckley, Cameron
    Badman, Steven
    Harris, Patrick
    Mackay, Ian
    Whiley, David
    DIAGNOSTICS, 2022, 12 (09)
  • [24] Genome Sequencing of the SARS-CoV-2 Delta (B.1.617.2) Variant of Concern Detected in Bangladesh
    Banu, Tanjina Akhtar
    Sarkar, M. Murshed Hasan
    Akter, Shahina
    Goswami, Barna
    Jahan, Iffat
    Osman, Eshrar
    Uzzaman, Mohammad Samir
    Habib, M. Ahashan
    Mahmud, Abu Sayeed Mohammad
    Uddin, Mohammad Mohi
    Nafisa, Tasnim
    Molla, M. Maruf Ahmed
    Yeasmin, Mahmuda
    Akram, Arifa
    Khan, M. Salim
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2021, 10 (48):
  • [25] Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
    Davis, Chris
    Logan, Nicola
    Tyson, Grace
    Orton, Richard
    Harvey, William T.
    Perkins, Jonathan S.
    Mollett, Guy
    Blacow, Rachel M.
    Peacock, Thomas P.
    Barclay, Wendy S.
    Cherepanov, Peter
    Palmarini, Massimo
    Murcia, Pablo R.
    Patel, Arvind H.
    Robertson, David L.
    Haughney, John
    Thomson, Emma C.
    Willett, Brian J.
    PLOS PATHOGENS, 2021, 17 (12)
  • [26] SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
    Jhun, Hyunjhung
    Park, Ho-Young
    Hisham, Yasmin
    Song, Chang-Seon
    Kim, Soohyun
    IMMUNE NETWORK, 2021, 21 (05)
  • [27] The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
    Lu, Lu
    Chu, Allen Wing-Ho
    Zhang, Ricky Ruiqi
    Chan, Wan-Mui
    Ip, Jonathan Daniel
    Tsoi, Hoi-Wah
    Chen, Lin-lei
    Cai, Jian-Piao
    Lung, David Christopher
    Tam, Anthony Raymond
    Yau, Yat-Sun
    Kwan, Mike Yat-Wah
    To, Wing-Kin
    Tsang, Owen Tak-Yin
    Lee, Larry Lap-Yip
    Yi, Haisu
    Ip, Tak-Chuen
    Poon, Rosana Wing-Shan
    Siu, Gilman Kit-Hang
    Mok, Bobo Wing-Yee
    Cheng, Vincent Chi-Chung
    Chan, Kwok Hung
    Yuen, Kwok-Yung
    Hung, Ivan Fan-Ngai
    Kai-Wang To, Kelvin
    EBIOMEDICINE, 2021, 71
  • [28] N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
    Tian, Fang
    Tong, Bei
    Sun, Liang
    Shi, Shengchao
    Zheng, Bin
    Wang, Zibin
    Dong, Xianchi
    Zheng, Peng
    ELIFE, 2021, 10
  • [29] First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain
    Barroso-Arevalo, Sandra
    Sanchez-Morales, Lidia
    Perez-Sancho, Marta
    Dominguez, Lucas
    Sanchez-Vizcaino, Jose M.
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [30] Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
    Jeican, Ionut Isaia
    Inisca, Patricia
    Gheban, Dan
    Anton, Vlad
    Lazar, Mihaela
    Vica, Mihaela Laura
    Mironescu, Daniela
    Rebeleanu, Codrin
    Crivii, Carmen Bianca
    Aluas, Maria
    Albu, Silviu
    Siserman, Costel Vasile
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):